Europe: High Cost Orphan Drug Treatments for Rare Diseases become Controversial

June 14, 2011 - PRLog -- According to a new report titled “Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues” available at http://www.reportbuyer.com/go/JPR00002 the orphan drug market faces hurdles at a national, regional and local level. This 143 page report analyses what these are and the strategies employed by successful orphan drug companies.

The price of treating uncommon diseases in a period when austerity measures are affecting total healthcare funding throughout Europe is a very controversial topic. There is a certified and urgent clinical need, a high patient demand and the treatments themselves can often offer the only hope. The report aims to determine if this is argument enough to declare premium prices and special status in a time of budget limitations, and strong demand for proof of clinical and cost effectiveness.
   
The orphan drug regulation no.141/2000, resulting in 724 selected products and 62 marketing approvals in the first 10 years, has without doubt been one of the most successful legislative processes taken by the EU. Boosting development and accelerating regulatory approval are very important, but alone do not guarantee orphan drugs are actually available for use. Rare disease patients need suitable access to therapies that are wholly funded by social health insurance and national health services.

The report “Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues” is available from Report Buyer at:
http://www.reportbuyer.com/pharma_healthcare/prescription...

Reportbuyer Product Code: JPR00002
   
Report Buyer http://www.reportbuyer.com/pharma_healthcare/prescription... the online store for global business information. The website now lists more than 200,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.